Tissue-agnostic drug approvals: how does this apply to patients with breast cancer?
e-ESO Podcasts - Een podcast door ESO - European School of Oncology
Categorieën:
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil
e-ESO Podcasts - Een podcast door ESO - European School of Oncology
Expert: Luiza Weis, Cancer Institute of Brasilia - ICB, Brasília, Brazil